Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX99
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,021.26 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by October 8, 2025, with an award date of September 17, 2025. The place of performance is Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026. The SPE2DB contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. EXPAREL, a local anesthetic used in surgical and post-operative pain management, represents one of the specialized pharmaceutical products within this broader pharmaceutical supply agreement. DMS Pharmaceutical Group has established itself as a significant supplier in the federal pharmaceutical supply chain through consistent contract performance delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZX99?
SPE2DB25FZX99 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FZX99 worth?
The government has obligated $5,021 on SPE2DB25FZX99.
Is contract SPE2DB25FZX99 an order under another contract?
Yes. SPE2DB25FZX99 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX99 competed?
The extent of competition for SPE2DB25FZX99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award